GlobeNewswire Inc | Jan 4, 2021 12:18PM EST

January 04, 2021

PRINCETON, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc.(Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will participate in a fireside chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference.

The fireside chat will be available for on-demand listening beginningMonday, January 11, 2021, at6:00 AM Eastern Timeon the Investors section of the Agile Therapeutics website atwww.agiletherapeutics.com, under the Events & Presentationstab. The archived webcast will be available for 30 days.

AboutAgile Therapeutics, Inc.Agile Therapeuticsis a women's healthcare company dedicated to fulfilling the unmet health needs of todays women. Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. For more information, please visit the company website atwww.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Companys website.

Follow Agile onLinkedInand Twitter:@AgileTher.

Contact:Matt RileyHead of Investor Relations & Corporate Communicationsmriley@agiletherapeutics.com